𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preoperative risk factors and early postoperative morbidity in CABG patients

✍ Scribed by P. Hantson; L. Jacquet; R. Dion; R. Verhelst; M. Goenen


Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
110 KB
Volume
4
Category
Article
ISSN
0888-6296

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Postoperative mortality in rectal cancer
✍ Dr T. Holm; L.-E. Rutqvist; H. Johansson; B. Cedermark πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 555 KB

Adjuvant preoperative radiotherapy in patients with rectal cancer improves local control and possibly overall survival. However, an increased postoperative mortality rate after radiotherapy has been observed in some trials. This study was based on 1399 patients in two randomized trials of radiother

Risk factors for early catheter-related
✍ Nicolas Penel; Jean-Charles Neu; StΓ©phanie Clisant; Helga Hoppe; Patrick Devos; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 110 KB

## Abstract ## BACKGROUND. Early catheter‐related infection is a serious complication in cancer treatment, although risk factors for its occurrence are not well established. The authors conducted a prospective study to identify the risk factors for developing early catheter‐related infection. ##

Risk factors for pulmonary complications
✍ Timothy M. McCulloch; Niels F. Jensen; Douglas A. Girod; Terance T. Tsue; Ernest πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 2 views

Background. Pulmonary complications are a primary source of increased cost and morbidity in surgically treated head and neck cancer patients. This study investigates potential risk factors related to postoperative pulmonary complications (pneumonia, adult respiratory distress syndrome (ARDS), and pr

Preoperative clinically inapparent leuco
✍ Daniel Reim; Norbert HΓΌser; Daniela Humberg; Alexander Novotny; Volker Assfalg; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 61 KB

## Abstract ## Background Since the recent MAGIC trial neoadjuvant chemotherapy has been considered as treatment option for patients with advanced gastric cancer for tumor‐downsizing and increasing R0 resection rates. Morbidity was reported in 45% of the patients treated within this randomized tri